CTSN -

Endocarditis

Click on hyperlinked text for illustrations


View TSDA Curriculum Online for this topic

1. Infective endocarditis:
Invasion of the endothelial surface of the heart by microorganisms
Infective microorganism may be:
Bacteria
Fungus
Rickettsia
Chlamydia
Virus
Commonly affects heart valves; also shunts (PDA), septal defects (VSD), coarctation of aorta
2. Predisposing Factors
Congenital lesions
Ventricular septal defects
Tetralogy of Fallot
Aortic stenosis
Complex cyanotic anomalies
Patent ductus arteriosus
Systemic to pulmonary arterial shunts
Acquired lesions
Rheumatic valvular disease
Degenerative cardiac lesions
3. Acute Infective Endocarditis
Toxicity marked
Progresses in days or weeks to valvular destruction and metastatic infection
Typically due to staphylococcus aureus
4. Subacute Infective Endocarditis (SBE)
Toxicity modest
Progresses over weeks to months, metastatic infection rare
Likely caused by streptococcus viridans, enterococci, staphylococcus epidermis, gram negative coccobacilli
5. Characteristic lesion: The Vegetation
A mass of platelets, fibrin and microorganisms
6. Native valve endocarditis - occurs on normal, congenitally deformed, or diseased valves
Aortic valve most common
Prosthetic valve endocarditis
10-20% of cases of endocarditis
Greatest risk during initial 6 months after valve surgery
Staphylococcus epidermis most common cause
Often extends beyond the valve into anulus and cardiac tissues
7. Pathogenesis
Intact endothelium is resistant to infection
Injury to heart valve endothelium leads to deposition of platelets and fibrin (nonbacterial thrombotic endocarditis)
Platelet - fibrin complex receptive to bacterial colonization
Bacteremia originates most commonly from oral mucosa, genitourinary or gastrointestinal tract
Fibronectin binds bacteria to platelet - fibrin complex (or to normal endothelium) - The vegetation grows, sheds organisms or fragments and embolizes
8. Pathophysiology
Constitutional symptom of infection
Locally destructive effects of infection
Embolization of vegetation
Continuous bacteremia with remote infection
Antibody response with tissue injury (eminent complex or antibody - complement reaction)
9. Constitutional Symptoms
Fever 80 - 85%
Chills 42 - 75%
Anorexia 25 - 55%
Malaise 25 - 40%
Weight loss 25 - 35%
10. Locally Destructive Effects of Infection
Perforation of valve leaflets
Perforation of fistula between blood vessels or cardiac chambers
Abscesses
Disruption of conduction system
11. Signs
Fever 80 - 90%
Murmur 80 - 85%
Changing or new 10-40%
Peripheral signs
Petechiae 10 - 40%
Splinter hemorrhages 5 - 15%
Osler’s nodes 7 - 10% (tender subcutaneous nodules in pulp of digits)
Janeway lesions 6 - 10% (erythematous, nontender lesions on palm or sole)
Roth spots 4 - 10% (retinal hemorrhage with pole center)
12. Emboli
Systemic emboli with infarction occur in 40%
Splenic (LUQ pain)
Renal (flank pain)
Cerebral (stroke 10 - 15%)
Coronary (common at autopsy, transmural infection rare)
Mesenteric (abdominal pain, ileus)
Retinal (blindness 3%)
Pulmonary emboli, often septic, occur
In 75% with tricuspid valve endocarditis
13. Diagnosis
High index of suspicion
Valvular heart disease
Prosthetic heart valve
Fever
Murmur
Positive blood culture
Echocardiogram (TEE = 82 - 94% +)
Vegetation
Dehiscence of prosthetic valve
New valvular regurgitation

Echocardiography

14. Fungal Endocarditis
5% of cases of NVE
10% of cases of PVE
Most common in IV drug abuse or underlying systemic disease
Diagnosis difficult, because many patients are afebrile with normal WBC

15. Fungus often difficult to culture, blood cultures typically negative
Large vegetations, systemic embolization, myocardial invasion, extremely resistant to medical therapy
Early surgical intervention warranted because medical mortality approaches 100% Anti-fungal therapy for life
16. Surgical Treatment - Absolute Indications
Congestive heart failure due to valve dysfunction
Unstable valve prosthesis
Uncontrolled infection
Persistent bacteremia
Fungal endocarditis
Relapse after optimal therapy (prosthesis)
Vegetation in Situ

17. Surgical Treatment - Relative Indications
Perivalvular extension of infection
Staphylococcal infection of prosthesis
Persistent fever (culture negative)
Large vegetation (> 10 mm = increased embolism)
Relapse after optimal therapy (native valve)
18. Treatment of Extracardiac Complications
Splenic abscess (3 - 5%)
Antibiotics
Percutaneous catheter drainage
Splenectomy
Mycotic aneurysm (2 - 10%, 1 - 5% cerebral)
Antibiotics
Surgery for aneurysm which expand or persist
Emerging operation for rupture
19. Principles of Surgical Management
Excision of all infected valve tissue
Drainage and debridement of abscess cavities
Repair or replacement of damaged valves
Repair of associated pathology: Septal defects, fistulas
20. Aortic Valve - Surgical Options
Infection limited to leaflets
Aortic valve replacement
Infection extends to anulus or beyond
Debride infected tissues
Drain abscesses to pericardial sac (? obliterate)
Replace aortic root
21. Atrioventricular Valve - Surgical Options
Infection limited to leaflets
Vegectomy
Repair perforations
Reduction annuloplasty
Infection extends to anulus or beyond
Valve replacement
Debride and abliterate abscesses
? Tricuspid valve excision
(20 - 30% develop CHF)
22. Results of Surgery
Mortality (operative) = 15 - 20%
Infection of prosthetic valve during operation for native valve endocarditis = 4%
(12 - 16% if active endocarditis)
Late survival (5 years)
Native valve = 70 - 80%
Prosthetic valve = 50 - 80%
ADDITIONAL MOVIES
Endocarditis - Echocardiogram, endocarditis tricuspid valve prosthesis
Endocarditis - Tricuspid valve replacement with mitral homograft, graft preparation
Endocarditis - Tricuspid valve replacement with mitral homograft, valve insertion
Endocarditis - Tricuspid valve replacement with mitral homograft, attach graft to annulus
Endocarditis - Tricuspid valve replacement with mitral homograft, completed repair
Endocarditis - Tricuspid valve replacement with mitral homograft, echocardiogram of completed repair